Atg5, Atg7 |
Nervous system-specific knockout (KO) |
Mouse |
Axonal swelling and degeneration; progressive postnatal loss of neurons (pyramidal neurons in the cerebral cortex and hippocampus, Purkinje cells in the cerebellum); organismal lethality |
19,20
|
Atg5, Atg7 |
Purkinje neuron-specific KO |
Mouse |
Axonal swelling and degeneration; progressive postnatal loss of Purkinje cells in the cerebellum and motor coordination decline; organismal lethality |
21,120
|
Fip200 |
Nervous system-specific KO |
Mouse |
Purkinje cell degeneration; progressive cerebellar ataxia; organismal lethality |
121 |
Ulk1/Ulk2 |
Nervous system-specific double KO |
Mouse |
Progressive loss of neurons (pyramidal neurons in the hippocampus CA1 region); elevated endoplasmic reticulum stress (activation of unfolded protein response pathway); organismal lethality |
122 |
Endophilin A |
Endophilin 1/2 double KO, Endophilin 1/3 double KO |
Mouse |
Progressive impairment in motor coordination, ataxia, neurodegeneration (motor cortex, hippocampus) |
66 |
Endophilin A KO |
Drosophila |
Loss of dopaminergic neurons |
43 |
Synaptojanin 1 |
Point mutation (R258Q) |
Drosophila |
Impaired autophagosome maturation, neurodegeneration (dopaminergic neuron loss) |
44 |
ATG5 |
Homozygous missense mutation |
Human |
Congenital ataxia; mental retardation; developmental delay |
123 |
WDR45 |
de novo mutations |
Human |
Neurodegeneration with brain iron accumulation (NBIA); abnormal iron deposition in substantia nigra and globus pallidus; developmental delay; neurological deterioration (parkinsonism, dystonia, early onset dementia) |
124–126
|